Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng-Ming Spring Kong

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
Journal of the American College of Radiology : JACR|July 30, 2013
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Joe Yujiao Chang, Indrin J Chetty, et al.
American Journal of Clinical Oncology|September 3, 2014
ACR appropriateness Criteria® early-stage non-small-cell lung cancerGregory M M Videtic, Joe Yujiao Chang, Indrin J Chetty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2018
Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancerFeng-Ming Spring Kong, Ling Li, Weili Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2024
Interpretable deep learning insights: Unveiling the role of 1 Gy volume on lymphopenia after radiotherapy in breast cancerFang Chen, Ping Zhou, Ge Ren, et al.
Oncotarget|January 18, 2018
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA scoreYongmei Liu, Lei Deng, Xiaojuan Zhou, et al.
Translational Oncology|December 9, 2017
Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine LevelsPeter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2019
Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical OpportunitiesAriel E Marciscano, Adriana Haimovitz-Friedman, Percy Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Radiation dose-volume effects in the lungLawrence B Marks, Soren M Bentzen, Joseph O Deasy, et al.
Annals of Translational Medicine|September 17, 2021
Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapyFang Chen, Hao Yu, Hong Zhang, et al.
Frontiers in Oncology|May 23, 2022
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast CancerFang Chen, Jian-Yue Jin, Timothy S K Hui, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
Journal of the American College of Radiology : JACR|July 30, 2013
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intentKenneth E Rosenzweig, Joe Yujiao Chang, Indrin J Chetty, et al.
American Journal of Clinical Oncology|September 3, 2014
ACR appropriateness Criteria® early-stage non-small-cell lung cancerGregory M M Videtic, Joe Yujiao Chang, Indrin J Chetty, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 4, 2018
Greater reduction in mid-treatment FDG-PET volume may be associated with worse survival in non-small cell lung cancerFeng-Ming Spring Kong, Ling Li, Weili Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 21, 2024
Interpretable deep learning insights: Unveiling the role of 1 Gy volume on lymphopenia after radiotherapy in breast cancerFang Chen, Ping Zhou, Ge Ren, et al.
Oncotarget|January 18, 2018
Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA scoreYongmei Liu, Lei Deng, Xiaojuan Zhou, et al.
Translational Oncology|December 9, 2017
Prediction of Radiation Esophagitis in Non-Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine LevelsPeter G Hawkins, Philip S Boonstra, Stephen T Hobson, et al.
International Journal of Radiation Oncology, Biology, Physics|March 6, 2019
Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical OpportunitiesAriel E Marciscano, Adriana Haimovitz-Friedman, Percy Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2010
Radiation dose-volume effects in the lungLawrence B Marks, Soren M Bentzen, Joseph O Deasy, et al.
Annals of Translational Medicine|September 17, 2021
Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapyFang Chen, Hao Yu, Hong Zhang, et al.
Frontiers in Oncology|May 23, 2022
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast CancerFang Chen, Jian-Yue Jin, Timothy S K Hui, et al.
Pageof 17